Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term surveillance of papillary thyroid cancer patients who do not undergo postoperative radioiodine remnant ablation: is there a role for serum thyroglobulin measurement?
Durante C, Montesano T, Attard M, Torlontano M, Monzani F, Costante G, Meringolo D, Ferdeghini M, Tumino S, Lamartina L, Paciaroni A, Massa M, Giacomelli L, Ronga G, Filetti S; PTC Study Group. Durante C, et al. Among authors: lamartina l. J Clin Endocrinol Metab. 2012 Aug;97(8):2748-53. doi: 10.1210/jc.2012-1123. Epub 2012 Jun 7. J Clin Endocrinol Metab. 2012. PMID: 22679061
Identification and optimal postsurgical follow-up of patients with very low-risk papillary thyroid microcarcinomas.
Durante C, Attard M, Torlontano M, Ronga G, Monzani F, Costante G, Ferdeghini M, Tumino S, Meringolo D, Bruno R, De Toma G, Crocetti U, Montesano T, Dardano A, Lamartina L, Maniglia A, Giacomelli L, Filetti S; Papillary Thyroid Cancer Study Group. Durante C, et al. Among authors: lamartina l. J Clin Endocrinol Metab. 2010 Nov;95(11):4882-8. doi: 10.1210/jc.2010-0762. Epub 2010 Jul 21. J Clin Endocrinol Metab. 2010. PMID: 20660054
Clinical aggressiveness and long-term outcome in patients with papillary thyroid cancer and circulating anti-thyroglobulin autoantibodies.
Durante C, Tognini S, Montesano T, Orlandi F, Torlontano M, Puxeddu E, Attard M, Costante G, Tumino S, Meringolo D, Bruno R, Trulli F, Toteda M, Redler A, Ronga G, Filetti S, Monzani F; PTC Study Group. Durante C, et al. Thyroid. 2014 Jul;24(7):1139-45. doi: 10.1089/thy.2013.0698. Epub 2014 May 21. Thyroid. 2014. PMID: 24702238 Free PMC article.
The natural history of benign thyroid nodules.
Durante C, Costante G, Lucisano G, Bruno R, Meringolo D, Paciaroni A, Puxeddu E, Torlontano M, Tumino S, Attard M, Lamartina L, Nicolucci A, Filetti S. Durante C, et al. Among authors: lamartina l. JAMA. 2015 Mar 3;313(9):926-35. doi: 10.1001/jama.2015.0956. JAMA. 2015. PMID: 25734734
BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study.
Tallini G, de Biase D, Durante C, Acquaviva G, Bisceglia M, Bruno R, Bacchi Reggiani ML, Casadei GP, Costante G, Cremonini N, Lamartina L, Meringolo D, Nardi F, Pession A, Rhoden KJ, Ronga G, Torlontano M, Verrienti A, Visani M, Filetti S. Tallini G, et al. Among authors: lamartina l. Mod Pathol. 2015 Oct;28(10):1343-59. doi: 10.1038/modpathol.2015.92. Epub 2015 Aug 14. Mod Pathol. 2015. PMID: 26271724 Free article.
Papillary thyroid carcinomas with biochemical incomplete or indeterminate responses to initial treatment: repeat stimulated thyroglobulin assay to identify disease-free patients.
Lamartina L, Montesano T, Trulli F, Attard M, Torlontano M, Bruno R, Meringolo D, Monzani F, Tumino S, Ronga G, Maranghi M, Biffoni M, Filetti S, Durante C. Lamartina L, et al. Endocrine. 2016 Nov;54(2):467-475. doi: 10.1007/s12020-015-0823-3. Epub 2015 Dec 14. Endocrine. 2016. PMID: 26668060
105 results